Volker Knappertz - EVP, Research and Development at Aurinia Pharmaceuticals Inc.

Issuer-level insider activity

Role
EVP, Research and Development
Issuer ticker
AUPH on Nasdaq
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by Volker Knappertz since 09 Aug 2025

Reported holdings for Volker Knappertz in Aurinia Pharmaceuticals Inc.

Form 4 holding EVP, Research and Development

Aurinia Pharmaceuticals Inc.

Security class
Common Stock
Shares / value
319,128
Estimated value
$1,946,681
Report date
27 Feb 2024
Price
$6.10
Ownership
Direct

Transaction history for Volker Knappertz in Aurinia Pharmaceuticals Inc.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .